The Shortcomings of Prior Authorizations in Evaluating Treatment Plans

PharMedQuest 2016-10-07

Views 25

PharMedQuest, an industry leader in Medical and Pharmaceutical Management Services, has developed a video explaining the shortcomings of using prior authorizations when trying to evaluate a multiple drug treatment plan, when not all of the drugs require a PA. The video is the latest in a series highlighting the solutions provided for specialty drug management under the Medical Benefit, including our proprietary state-of-the-art technology platform, ARC™.

More information can be found at www.PharMedQuest.com.

Share This Video


Download

  
Report form